These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 8847818)
1. [Changes of factor XIII a and b subunit in patients with disseminated intravascular coagulation syndrome]. Sugimura D; Fukue H; Arai M; Matsumoto K; Fukutake K Rinsho Byori; 1996 Apr; 44(4):355-61. PubMed ID: 8847818 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation. Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212 [TBL] [Abstract][Full Text] [Related]
3. A contribution to the pathology of acquired plasma factor XIII deficiency. Ballerini G; Guerra S; Rodeghiero F; Castaman G Semin Thromb Hemost; 1985 Oct; 11(4):357-61. PubMed ID: 4071061 [TBL] [Abstract][Full Text] [Related]
4. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation]. Fukuda C; Iijima K; Nakamura K Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061 [TBL] [Abstract][Full Text] [Related]
5. A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2). Katona E; Haramura G; Kárpáti L; Fachet J; Muszbek L Thromb Haemost; 2000 Feb; 83(2):268-73. PubMed ID: 10739385 [TBL] [Abstract][Full Text] [Related]
6. [Studies on the blood coagulation factor XIII in patients with increased levels of FDP D-dimer]. Okumura N; Matsuzawa A; Terasawa F; Kameko M; Sasaki Y; Nakagoshi R; Ishikawa S; Hashikura Y; Matsunami H; Kawasaki S Rinsho Byori; 1995 Mar; 43(3):269-74. PubMed ID: 7745833 [TBL] [Abstract][Full Text] [Related]
7. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)]. Koga S Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605 [TBL] [Abstract][Full Text] [Related]
8. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A. Pfitzner SA; Dempfle CE; Matsuda M; Heene DL Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756 [TBL] [Abstract][Full Text] [Related]
9. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation. Seo JW; Kim HK; Kim JE; Park S; Cho HI Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738 [TBL] [Abstract][Full Text] [Related]
10. Fibrin stabilizing factor (factor XIII) consumption as an indicator of disseminated intravascular coagulation (DIC). Zuch A; Kloczko J; Bielawiec M; Myśliwiec M; Grabowski R; Buluk K Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(6):874-8. PubMed ID: 75158 [No Abstract] [Full Text] [Related]
11. Reduction of coagulation factor XIII concentration in patients with myocardial infarction, cerebral infarction, and other thromboembolic disorders. Alkjaersig N; Fletcher AP; Lewis M; Ittyerah R Thromb Haemost; 1977 Dec; 38(4):863-73. PubMed ID: 579691 [TBL] [Abstract][Full Text] [Related]
13. Microtiter assay for measurement of factor XIII activity in plasma. Dempfle CE; Harenberg J; Hochreuter K; Heene DL J Lab Clin Med; 1992 May; 119(5):522-8. PubMed ID: 1349910 [TBL] [Abstract][Full Text] [Related]
14. [Approach of hematology. Abnormal findings of coagulation and fibrinolytic factors in DIC]. Ikematsu S; Kato M; Kuroso K Rinsho Byori; 1984 Aug; 32(8):862-8. PubMed ID: 6502985 [No Abstract] [Full Text] [Related]
15. Molecular subunits and transamidase activity of factor XIII in patients with deep vein thrombosis. Kłoczko J; Wojtukiewicz M; Bielawiec M Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):810-4. PubMed ID: 2436995 [TBL] [Abstract][Full Text] [Related]
16. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation. Langer F; Spath B; Haubold K; Holstein K; Marx G; Wierecky J; Brümmendorf TH; Dierlamm J; Bokemeyer C; Eifrig B Ann Hematol; 2008 Jun; 87(6):451-7. PubMed ID: 18292996 [TBL] [Abstract][Full Text] [Related]
17. Physiopathology and regulation of factor XIII. Ichinose A Thromb Haemost; 2001 Jul; 86(1):57-65. PubMed ID: 11487042 [TBL] [Abstract][Full Text] [Related]
18. [Hemostatic abnormalities in DIC]. Wada H Rinsho Byori; 2002 Aug; 50(8):768-72. PubMed ID: 12373812 [TBL] [Abstract][Full Text] [Related]
19. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Levi M; Toh CH; Thachil J; Watson HG Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital -- meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation. Cauchie P; Cauchie Ch; Boudjeltia KZ; Carlier E; Deschepper N; Govaerts D; Migaud-Fressart M; Woodhams B; Brohée D Am J Hematol; 2006 Jun; 81(6):414-9. PubMed ID: 16680742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]